Phenotype-Genotype Correlation in Familial Breast Cancer

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

(2010) Yonglan Zheng et al.   BREAST CANCER RESEARCH AND TREATMENT

Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer

(2010) Chenyou Jia et al.   BREAST CANCER RESEARCH AND TREATMENT

Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls

(2010) O. Fletcher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2010) C. Engel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America

(2010) Maria D. Iniesta et al.   CANCER GENETICS AND CYTOGENETICS

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

(2010) M. Tischkowitz et al.   CANCER RESEARCH

Lynch Syndrome-Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

(2010) M. D. Walsh et al.   CLINICAL CANCER RESEARCH

Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families

(2010) Rosemary L. Balleine et al.   GENES CHROMOSOMES & CANCER

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

(2010) M. W. G. Ruijs et al.   JOURNAL OF MEDICAL GENETICS

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations

(2010) J. R. F. Wilson et al.   JOURNAL OF MEDICAL GENETICS

Pathology of hereditary breast cancer

(2010) Leonard Da Silva et al.   MODERN PATHOLOGY

miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors

(2010) Patryk Moskwa et al.   MOLECULAR CELL

Fanconi anemia and breast cancer susceptibility meet again

(2010) Ephrat Levy-Lahad   NATURE GENETICS

Mutation of the RAD51C gene in a Fanconi anemia–like disorder

(2010) Fiona Vaz et al.   NATURE GENETICS

Susceptibility Pathways in Fanconi's Anemia and Breast Cancer

(2010) Alan D. D'Andrea   NEW ENGLAND JOURNAL OF MEDICINE

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

(2010) N Turner et al.   ONCOGENE

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

(2010) K. J. Dedes et al.   Science Translational Medicine

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

(2010) Mia M. Gaudet et al.   PLoS Genetics

Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer

(2009) Sean V. Tavtigian et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers

(2009) Laura C. Collins et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling

(2009) M. Pensabene et al.   ANNALS OF ONCOLOGY

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

(2009) Uffe Birk Jensen et al.   BREAST CANCER RESEARCH AND TREATMENT

ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy

(2009) Laura La Paglia et al.   BREAST CANCER RESEARCH AND TREATMENT

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features

(2009) E. Barroso et al.   BREAST CANCER RESEARCH AND TREATMENT

Association of rare MSH6 variants with familial breast cancer

(2009) Marijke Wasielewski et al.   BREAST CANCER RESEARCH AND TREATMENT

Common Genetic Variation in Candidate Genes and Susceptibility to Subtypes of Breast Cancer

(2009) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Histopathological criteria and selection algorithms for BRCA1 genetic testing

(2009) Dorothea Gadzicki et al.   CANCER GENETICS AND CYTOGENETICS

High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

(2009) H. Holstege et al.   CANCER RESEARCH

High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors

(2009) E. Manie et al.   CANCER RESEARCH

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

(2009) E Barrow et al.   CLINICAL GENETICS

BeyondBRCA1andBRCA2wild-type breast and/or ovarian cancer families: germline mutations inTP53andPTEN

(2009) A Blanco et al.   CLINICAL GENETICS

Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors

(2009) Ana M. Mendes-Pereira et al.   EMBO Molecular Medicine

Breast cancer immunohistochemistry can be useful in triage of some HNPCC families

(2009) S. Shanley et al.   Familial Cancer

Identification and characterization of a novel germlinep53mutation in a patient with glioblastoma and colon cancer

(2009) Hidetaka Yamada et al.   INTERNATIONAL JOURNAL OF CANCER

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

(2009) Julie Tinat et al.   JOURNAL OF CLINICAL ONCOLOGY

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families Withp53Germline Mutations

(2009) Kelly D. Gonzalez et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY

Fanconi anemia and its diagnosis

(2009) Arleen D. Auerbach   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

(2009) Elgene Lim et al.   NATURE MEDICINE

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2008) Antonis C. Antoniou et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast

(2008) Leonard Da Silva et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Mechanism of Eukaryotic Homologous Recombination

(2008) Joseph San Filippo et al.   Annual Review of Biochemistry

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

(2008) T. Byrski et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors

(2008) Anita L. Bane et al.   BREAST CANCER RESEARCH AND TREATMENT

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

(2008) S E Elsheikh et al.   BRITISH JOURNAL OF CANCER

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

(2008) S. Zhang et al.   CANCER RESEARCH

Targeted therapy for cancer using PARP inhibitors

(2008) Christopher J Lord et al.   CURRENT OPINION IN PHARMACOLOGY

Expression of BRCA1 protein in breast cancer and its prognostic significance

(2008) Emad A. Rakha et al.   HUMAN PATHOLOGY

Clinically Applicable Models to CharacterizeBRCA1andBRCA2Variants of Uncertain Significance

(2008) Andrew D. Spearman et al.   JOURNAL OF CLINICAL ONCOLOGY

Hereditary breast cancer: from molecular pathology to tailored therapies

(2008) D S P Tan et al.   JOURNAL OF CLINICAL PATHOLOGY

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

(2008) PT Simpson et al.   JOURNAL OF PATHOLOGY

Molecular and in silico analysis of BRCA1 and BRCA2 variants☆

(2008) Stefania Tommasi et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

(2008) Simon N Stacey et al.   NATURE GENETICS

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

(2008) Montserrat Garcia-Closas et al.   PLoS Genetics

The emerging landscape of breast cancer susceptibility

(2007) Michael R Stratton et al.   NATURE GENETICS